Classifying Schizophrenia Using Multimodal Multivariate Pattern Recognition Analysis: Evaluating the Impact of Individual Clinical Profiles on the Neurodiagnostic Performance.

Journal: Schizophrenia bulletin
Published Date:

Abstract

Previous studies have shown that structural brain changes are among the best-studied candidate markers for schizophrenia (SZ) along with functional connectivity (FC) alterations of resting-state (RS) patterns. This study aimed to investigate effects of clinical and sociodemographic variables on the classification by applying multivariate pattern analysis (MVPA) to both gray matter (GM) volume and FC measures in patients with SZ and healthy controls (HC). RS and structural magnetic resonance imaging data (sMRI) from 74 HC and 71 SZ patients were obtained from a Mind Research Network COBRE dataset available via COINS (http://coins.mrn.org/dx). We used a MVPA framework using support-vector machines embedded in a repeated, nested cross-validation to generate a multi-modal diagnostic system and evaluate its generalizability. The dependence of neurodiagnostic performance on clinical and sociodemographic variables was evaluated. The RS classifier showed a slightly higher accuracy (70.5%) compared to the structural classifier (69.7%). The combination of sMRI and RS outperformed single MRI modalities classification by reaching 75% accuracy. The RS based moderator analysis revealed that the neurodiagnostic performance was driven by older SZ patients with an earlier illness onset and more pronounced negative symptoms. In contrast, there was no linear relationship between the clinical variables and neuroanatomically derived group membership measures. This study achieved higher accuracy distinguishing HC from SZ patients by fusing 2 imaging modalities. In addition the results of RS based moderator analysis showed that age of patients, as well as their age at the illness onset were the most important clinical features.

Authors

  • Carlos Cabral
    Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany; These authors contributed equally.
  • Lana Kambeitz-Ilankovic
    Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany; These authors contributed equally. Lana.Kambeitz-Ilankovic@med.uni-muenchen.de.
  • Joseph Kambeitz
    Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany;
  • Vince D Calhoun
    Mind Research Network & Lovelace Biomedical and Environmental Research Institute, Albuquerque, New Mexico; Department of Psychiatry and Behavioral Sciences, University of New Mexico, Albuquerque, New Mexico; Department of Electrical and Computer Engineering, University of New Mexico, Albuquerque, New Mexico; Department of Neurosciences, University of New Mexico, Albuquerque, New Mexico.
  • Dominic B Dwyer
    Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany;
  • Sebastian von Saldern
    Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany;
  • Maria F Urquijo
    Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany;
  • Peter Falkai
    Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany;
  • Nikolaos Koutsouleris
    Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.